Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-10-20

Clinical Trial Update: Effects of PAP Treatment of OSA in Patients With Heart Failure [NA]

View source ↗

Summary

The clinical trial NCT01136122 evaluating PAP treatment for obstructive sleep apnea in patients with heart failure has been withdrawn, with no results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ulysses Magalang MD | Conditions: Obstructive Sleep Apnea | NA | Status: WITHDRAWN